Aurobindo Pharma arm’s biosimilar gets Health Canada NOC
Share:
A notice of compliance from Health Canada is issued to a drug manufacturer after a successful review, confirming the product meets regulatory standards for safety, efficacy and quality under the Food and Drug Regulations Read full article
TV19 News Desk represents the official editorial team responsible for publishing syndicated and agency-sourced content. Articles attributed to this account are curated from verified RSS feeds and published in accordance with TV19 News editorial standards.
Comments (0)